Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$3.2 - $4.98 $38,534 - $59,969
-12,042 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$3.69 - $7.09 $2,608 - $5,012
-707 Reduced 5.55%
12,042 $47,000
Q2 2020

Aug 13, 2020

SELL
$3.58 - $7.44 $10,288 - $21,382
-2,874 Reduced 18.4%
12,749 $95,000
Q1 2020

May 13, 2020

SELL
$3.49 - $9.2 $369 - $975
-106 Reduced 0.67%
15,623 $70,000
Q4 2019

Feb 14, 2020

SELL
$6.27 - $11.41 $3,473 - $6,321
-554 Reduced 3.4%
15,729 $145,000
Q3 2019

Nov 08, 2019

BUY
$4.75 - $8.38 $24,134 - $42,578
5,081 Added 45.36%
16,283 $114,000
Q2 2019

Aug 07, 2019

SELL
$6.4 - $10.94 $1,350 - $2,308
-211 Reduced 1.85%
11,202 $79,000
Q1 2019

Apr 30, 2019

BUY
$6.1 - $10.3 $4,849 - $8,188
795 Added 7.49%
11,413 $118,000
Q4 2018

Feb 12, 2019

BUY
$5.84 - $11.92 $62,009 - $126,566
10,618 New
10,618 $66,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $40M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.